60 Degrees Pharmaceuticals, Inc. financial data

Symbol
SXTP, SXTPW on Nasdaq
Location
1025 Connecticut Avenue Nw, Suite 1000, Washington, DC
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 288 % -27.7%
Quick Ratio 34.6 % +25.8%
Debt-to-equity 52.9 % +58.2%
Return On Equity -217 % -43.1%
Return On Assets -141 % -24.4%
Operating Margin -838 % +56.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.23M shares +84.1%
Common Stock, Shares, Outstanding 4.1M shares +120%
Entity Public Float 2.7M USD -76.6%
Common Stock, Value, Issued 410 USD +120%
Weighted Average Number of Shares Outstanding, Basic 3.68M shares +652%
Weighted Average Number of Shares Outstanding, Diluted 3.68M shares +70.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 944K USD +92%
Cost of Revenue 779K USD +88.7%
Research and Development Expense 2.08M USD -53.5%
General and Administrative Expense 6.41M USD +25.5%
Operating Income (Loss) -7.91M USD +17.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.98M USD -0.31%
Income Tax Expense (Benefit) 1.31K USD +61.6%
Net Income (Loss) Attributable to Parent -7.97M USD -0.72%
Earnings Per Share, Basic 1 USD/shares +85.8%
Earnings Per Share, Diluted 0 USD/shares +77.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.12M USD +24.7%
Cash, Cash Equivalents, and Short-term Investments 4.12M USD
Accounts Receivable, after Allowance for Credit Loss, Current 674K USD +108%
Inventory, Net 527K USD +16.6%
Assets, Current 6.31M USD -8.44%
Property, Plant and Equipment, Net 228K USD +46.7%
Operating Lease, Right-of-Use Asset 13.5K USD +6.88%
Intangible Assets, Net (Excluding Goodwill) 152K USD -42.4%
Other Assets, Noncurrent 152K USD -59.3%
Assets 6.69M USD -9.86%
Liabilities, Current 2.2M USD +67.7%
Liabilities 2.34M USD +60.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 144K USD +3.47%
Retained Earnings (Accumulated Deficit) -46.5M USD -20.7%
Stockholders' Equity Attributable to Parent 4.43M USD -26.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 4.35M USD -27.1%
Liabilities and Equity 6.69M USD -9.86%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.6M USD -40.1%
Net Cash Provided by (Used in) Financing Activities 1.7M USD -10.8%
Net Cash Provided by (Used in) Investing Activities 1.7M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 4.1M shares +120%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.79M USD +138%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.12M USD +24.7%
Deferred Tax Assets, Valuation Allowance 5.92M USD +91.6%
Deferred Tax Assets, Gross 5.98M USD +58%
Operating Lease, Liability 26.8K USD
Depreciation 18K USD +22.8%
Payments to Acquire Property, Plant, and Equipment 2.68K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7.97M USD -1.4%
Lessee, Operating Lease, Liability, to be Paid 13.7K USD
Property, Plant and Equipment, Gross 403K USD +34.8%
Operating Lease, Liability, Current 529K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 14K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 14K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.15 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14K USD
Deferred Tax Assets, Operating Loss Carryforwards 4.19M USD +19.8%
Preferred Stock, Shares Issued 78.8K shares
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 41.2M USD +18.3%
Preferred Stock, Shares Outstanding 78.8K shares
Amortization of Intangible Assets 41.6K USD +2.71%
Depreciation, Depletion and Amortization 33.6K USD +182%
Deferred Tax Assets, Net of Valuation Allowance 68.8K USD -90.2%
Share-based Payment Arrangement, Expense 406K USD -88.2%
Interest Expense 2.29M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%